PatternsRadar
Sign in

3BBLACKBIO3B Blackbio Dx Limited

NSE
1,305.10INR-11.50 (-0.87%)Close · 20 Nov 2026
—Last results
HealthcareSector
Healthcare ServicesIndustry
₹1,120 CrMarket cap
—P/E (TTM)
64.1%Delivery

Filings & corporate actions

CSV
Dividend
₹5.00 per share · last 22 Sept 2026
2026
  • 22 SeptdividendDividend · ₹5.00 per share · record 22 Sept 2026-2.7%

Growth

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open1,316.00
Day range1,298.30 – 1,320.00
52-week range—
From 52w high—
RSI (14)43.6
ATR (14)65.08
Volume5.8K
Avg volume (20D)13.1K
Rel volume0.45×
Volatility (1Y)50.5%
Turnover₹76.2L
Traded value (NSE)₹76.2L
VWAP1,305.29
SMA 50 / 2001,410.83 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202664.1%
20-day avg56.1%
1-year avg58.4%
Percentile (own history)72nd
Range16.5–89.3%
Sessions149

Over the last 20 sessions 3BBLACKBIO settled 56.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 58.4%, so recent sessions are running 2.3 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.38%
Dividend, trailing 12M₹5.00
Paid every year for1 yr
Shareholders—
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever
IndustryHealthcare Service Provider

Performance returns

1D1W1M3M6M1Y
Price-0.87%-2.71%-3.28%+13.38%+8.60%—

Valuation

Market cap₹1,120 Cr
Market cap (NSE)₹1,120 Cr
Free-float cap—
P/E (TTM)—
EPS (TTM)—
P/B—
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity—
Shares outstanding—
Listed20 Apr 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

Dividends

since 22 Sept 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹5.00₹5.00
Ex-dateRecord dateDeclaredAdjusted
22 Sept 202622 Sept 2026₹5.00₹5.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to 3BBLACKBIO.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

3BBLACKBIO at a glance

  • 3BBLACKBIO closed at ₹1,305.1 on 20 Nov 2026, -0.87% on the day.
  • Delivery was 64.1% of traded quantity on 20 Nov 2026, the 72nd percentile of its own 149 sessions with a reading (20-session average 56.1%, 1-year average 58.4%).
  • Market capitalisation is ₹1,120 crore, with no positive trailing earnings for a P/E.

About

Macro sectorHealthcare
Basic industryHealthcare Service Provider
ISININE994E01018
SeriesEQ
Listed20 Apr 2026
NSE market cap · 17 Nov 2026₹1,157 Cr
Free-float market cap (NSE)₹669 Cr
Shares outstanding (NSE)85.83L
History from20 Apr 2026
Sessions149

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.